Celldex Therapeutics (CLDX) Tops Q1 EPS by 3c

Celldex Therapeutics (NASDAQ: CLDX) reported Q1 EPS of ($0.33), $0.03 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $406 thousand versus the consensus estimate of $460 thousand.

For earnings history and earnings-related data on (CLDX) click here.

You May Also Be Interested In

• Pelagos Insurance Capital (PLGO) PT Raised to $28 at Citizens on Rising Book Value
• Fiserv (FISV) PT Lowered to $62 at Baird, 'designating as a bearish Fresh Pick into earnings'
• Chevron (CVX) PT Lowered to $224 at Mizuho